Skip to main content

Table 2 Bias assessment of each study

From: Step counter use in type 2 diabetes: a meta-analysis of randomized controlled trials

Author, year

Random sequence generation

Allocation concealment

Blinding of participants and personnel

Blinding of outcome assessment

Incomplete outcome data addressed

Selective reporting

De Greef et al. 2011-1 [24]

Low

Low

Low

Low

Low

Low

De Greef et al. 2010 [25]

Low

Low

Low

Low

Low

Low

Tudor-Locke et al. 2004 [26]

Unclear

Unclear

Low

Low

High

Low

Piette et al. 2011 [27]

Low

Low

Low

Low

High

Low

De Greef et al. 2011-2 [28]

Unclear

Unclear

Low

Low

Low

Low

Kirk et al. 2009 [29]

Low

Low

Low

Low

Low

Low

Plotnikoff et al. 2013 [30]

Low

Low

Low

Low

High

Low

Engel et al. 2006 [31]

Unclear

Unclear

Low

Low

High

Low

Bjørgaas et al. 2008 [18]

Unclear

Unclear

Low

Low

High

Low

Andrews et al. 2011 [32]

Low

Low

Low

Low

Low

Low

Diedrich et al. 2010 [33]

Unclear

Unclear

Low

Low

High

Low

  1. Summary assessments of the risk of bias for each RCT within studies:
  2. Low risk of bias, low risk of bias for all key domains; unclear risk of bias, unclear risk of bias for one or more key domains; high risk of bias, high risk of bias for one or more key domains.